LTZ Therapeutics

Verified by our team

  • Biotech
Linkedin Twitter Facebook

LTZ Therapeutics is a global biotech company focused on immunotherapy, developing innovative treatments for oncology and autoimmune diseases. Its pioneering myeloid engager platform leverages macrophages to improve patient outcomes, with the bold goal of eliminating cancer.

LTZ Therapeutics Highlights:

  • LTZ Therapeutics annual revenue is $2.6M.
  • LTZ Therapeutics total funding is $27.0M.
  • LTZ Therapeutics headquartered in Redwood City, California.
  • LTZ Therapeutics number of employees is 33.

    • Overview

    • Website: ltztherapeutics.com
    • Headquarters: Redwood City, California
    • Employees: 33
    • Founded: 2022
    • Email: info@ltztherapeutics.com
    • Funding: $27.0M
    • Revenue: $2.6M
    • Valuation: n/a

    Contacts

    Robert Li

    CEO
    Linkedin
    • Email: ***@ltztherapeutics.com
    Buy the List to Unlock Contacts

    Similar companies

    Frequently Asked Questions related to LTZ Therapeutics

    LTZ Therapeutics is located in Redwood City, California.
    Yes, LTZ Therapeutics is a Silicon Valley company.
    LTZ Therapeutics total funding is 27.0M.
    LTZ Therapeutics revenue is 2.6M.
    LTZ Therapeutics’s number of employees is 33.
    LTZ Therapeutics’s CEO name is Robert Li.
    LTZ Therapeutics was founded in 2022.
    LTZ Therapeutics’s contact email is info@ltztherapeutics.com.

    Follow Silicon Valley Journals

    Awarded by

    corporate vision magazine

    © Copyright 2022-2024 Silicon Valley Journals. All rights reserved.

    Fundings

    Quick links

    Company

    © Copyright SVJ Media Ltd., 71-75 Shelton Street. Covent Garden. London, GB WC2H 9JQ